Compounds > 1-((beta-mercapto-beta)beta cyclopentamethylenepropionic acid)-2-(o-ethyl-tyr)-4-val-9-des-gly-arginine vasopressin
Page last updated: 2024-09-03

1-((beta-mercapto-beta)beta cyclopentamethylenepropionic acid)-2-(o-ethyl-tyr)-4-val-9-des-gly-arginine vasopressin and Pregnancy

1-((beta-mercapto-beta)beta cyclopentamethylenepropionic acid)-2-(o-ethyl-tyr)-4-val-9-des-gly-arginine vasopressin has been researched along with Pregnancy in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Summerlee, AJ; Wilson, BC1

Other Studies

1 other study(ies) available for 1-((beta-mercapto-beta)beta cyclopentamethylenepropionic acid)-2-(o-ethyl-tyr)-4-val-9-des-gly-arginine vasopressin and Pregnancy

ArticleYear
Effects of exogenous relaxin on oxytocin and vasopressin release and the intramammary pressure response to central hyperosmotic challenge.
    The Journal of endocrinology, 1994, Volume: 141, Issue:1

    Topics: Animals; Arginine Vasopressin; Female; Hypertonic Solutions; Lactation; Mammary Glands, Animal; Osmolar Concentration; Oxytocin; Pregnancy; Pressure; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Relaxin; Sodium Chloride; Stimulation, Chemical; Time Factors; Vasopressins

1994